- Global Pharma News & Resources

Flu Vaccine Market to See Huge Growth by 2027 | GlaxoSmithKline Plc, Sanofi Pasteur SA, Pfizer, Inc.

Pune, Maharashtra, India, January 14 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Flu Vaccine Market, in terms of revenue, was worth of USD 4.82 Billion in 2018 and is expected to reach USD 7.06 Billion in 2025, growing at a CAGR of 5.64 % from 2019 to 2025.

Increasing government initiatives for wellbeing of population, minimum side effects associated with influenza vaccines, improvement in existing vaccines and development of new vaccines are some of the major factors driving the market growth.

Additionally, funding and investments by major companies in research and development activities supports the growth of global market. Increasing cases of flu diseases among geriatric as well as pediatric population is helping to increase the market demand in flu seasons. On the positive side, rising number of routine immunization programs in developed as well as emerging countries is also expected to provide more opportunities for flu vaccine market growth.

Get Sample of This Report@

Scope of The Report:

Flu Vaccine Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Flu Vaccine Market place for the forecast 2019– 2025. The global Flu vaccine is expected to grow at a significant rate due to the number of driving factors.

The study provides a crucial view of global Flu vaccine market by segmenting the market based on vaccine type, technology, application and region. On the basis of product type, the market is segmented into trivalent and quadrivalent. On the basis of technology, the market is segmented into egg based and cell based. Based upon application, the market is segmented into pediatrics and adults. On the basis of country level, global Flu vaccine market sub-divided into U.S., Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Brazil, Mexico, GCC, Africa, etc.

Flu Vaccine Manufacturers

Seqirus GlaxoSmithKline Plc Sanofi Pasteur SA MedImmune CSL Limited Merck Sharp & Dohme Corp. Pfizer, Inc. Gamma Vaccines Pty Ltd Sinovac Biotech Ltd OPKO Health, Inc.

Flu Vaccine Market Key Market Segments:

By Vaccine type: Quadrivalent, Trivalent

By Type: Seasonal, Pandemic

By Technology: Egg-based, Cell-based

By Age Group: Pediatric, Adult

By Route of Administration: Injection, Nasal Spray

Full Research Report @         

Other Related Reports –

About us: Brandessence Market Research and Consulting Pvt. Ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at






This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 14-Jan-2021